These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27246838)

  • 1. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
    Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
    Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
    Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
    Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21.
    Dai B; Hu Z; Huang H; Zhu G; Xiao Z; Wan W; Zhang P; Jia W; Zhang L
    Biochem Biophys Res Commun; 2014 Nov; 454(1):221-7. PubMed ID: 25450384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
    Huang YQ; Zou Y; Zheng RJ; Ma XD
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
    Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
    Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.
    Sun LL; Sun XX; Xu XE; Zhu MX; Wu ZY; Shen JH; Wu JY; Huang Q; Li EM; Xu LY
    Acta Histochem; 2013 Jan; 115(1):56-62. PubMed ID: 22534467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
    Wang W; Zheng K; Pei Y; Zhang X
    Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.
    Shen X; Zhuang Z; Zhang Y; Chen Z; Shen L; Pu W; Chen L; Xu Z
    Tumour Biol; 2015 Sep; 36(9):7133-42. PubMed ID: 25877751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
    Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
    Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
    Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
    Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JARID1B is a luminal lineage-driving oncogene in breast cancer.
    Yamamoto S; Wu Z; Russnes HG; Takagi S; Peluffo G; Vaske C; Zhao X; Moen Vollan HK; Maruyama R; Ekram MB; Sun H; Kim JH; Carver K; Zucca M; Feng J; Almendro V; Bessarabova M; Rueda OM; Nikolsky Y; Caldas C; Liu XS; Polyak K
    Cancer Cell; 2014 Jun; 25(6):762-77. PubMed ID: 24937458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.
    Kim J; Shin S; Subramaniam M; Bruinsma E; Kim TD; Hawse JR; Spelsberg TC; Janknecht R
    Biochem Biophys Res Commun; 2010 Oct; 401(3):412-6. PubMed ID: 20863814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
    Zhang L; Sokolowski N; Atmadibrata B; Liu T
    Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
    Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
    BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.
    Lu W; Liu S; Li B; Xie Y; Adhiambo C; Yang Q; Ballard BR; Nakayama KI; Matusik RJ; Chen Z
    Oncotarget; 2015 Jan; 6(2):771-88. PubMed ID: 25596733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
    Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
    Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of JARID1B induces cellular senescence in human colorectal cancer.
    Ohta K; Haraguchi N; Kano Y; Kagawa Y; Konno M; Nishikawa S; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Noguchi Y; Ozaki M; Kudo T; Sakai D; Satoh T; Fukami M; Ishii M; Yamamoto H; Doki Y; Mori M; Ishii H
    Int J Oncol; 2013 Apr; 42(4):1212-8. PubMed ID: 23354547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast.
    Zhao LH; Liu HG
    Genet Mol Res; 2015 May; 14(2):5417-26. PubMed ID: 26125737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.
    Wang L; Mao Y; Du G; He C; Han S
    Tumour Biol; 2015 Apr; 36(4):2465-72. PubMed ID: 25663457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.